<!doctype html>

<html lang="en">
<head>
    <meta charset="utf-8">
    <meta content="IE=edge" http-equiv="X-UA-Compatible">
    <meta content="width=device-width, initial-scale=1.0" name="viewport">
    <title>GA TB Reference Guide </title>
    <meta content="GA TB Reference Guide" name="description">
    <meta content="SitePoint" name="author">
    <link href="../assets/uikit.css" rel="stylesheet">
    <link href="../assets/style.css" rel="stylesheet">

</head>

<body>

<div class="uk-container">
    <div class="chapter-header">
        <div class="header-title">
            <div>
                <img src="ic_chart.svg"  class="ic_chapter_icon">
            </div>
            <p class="chapter-title">11. Antituberculosis Medications for Patients who have Contraindications to or Intolerance of First Line Agents or require IV Therapy during Acute or Critical Illness.</p>
        </div>
        <p> <span class="view-in-chapter-highlight"> View in chapter → <span> <a href="5_treatment_of_current_(active)_disease_therapy__c__special_clinical_situations.html#table11"> Special Clinical Situations </a></p>
        <p class="last-updated"><i>Last Updated October 2025</i></p>
    </div>
    <hr>
    <div class="uk-overflow-auto"
         id="table_11_antituberculosis_medications_which_may_be_used_for_patients_who_have_contraindications_to_or_intolerance">

        <div class="uk-tabs-container">
            <ul class="tabs">
                <li><button class="tab-button active-option" onclick="switchTab(0, event)">Levofloxacin: PO/IV</button></li>

                <li>
                    <button class="tab-button" onclick="switchTab(1, event)">Moxifloxacin: PO/IV</button>
                </li>

                <li><button class="tab-button" onclick="switchTab(2, event)">Linezolid: PO/IV</button></li>

                <li><button class="tab-button" onclick="switchTab(3, event)">Amikacin: IV</button></li>
            </ul>
        </div>

        <div id="option-content" class="option-content active-option">
            <table class="uk-table uk-table-small">
                <tbody>
                    <tr>
                        <th class="uk-table-expand">Dosing </th>
                        <td>
                            <strong class="highlight">Adults</strong> <br>
                            750 mg <br><br>
                            <strong class="highlight">Children</strong> <br>
                            15 - 20 mg <br><br>
                            <strong class="highlight">Max dose</strong> <br> 750 mg
                        </td>
                    </tr>
                    <tr>
                        <th>Frequency</th>
                        <td>Daily</td>
                    </tr>
                    <tr>
                        <th>Adverse Reactions</th>
                        <td>
                            GI upset, dizziness, hypersensitivity, Headaches, QT prolongation, tendon rupture (rare), arthralgia, increased risk for aortic dissection/rupture, hypo/hyperglycemia
                        </td>
                    </tr>
                </tbody>
            </table>

            <p>Additional Notes:</p>
            <p>
                Dosing above for persons with CrCL > 50 mL/min. For persons with renal impairment, see Table 13. Expert consultation is advised before use; agent is not approved for children less than 18 years of age.
            </p>
        </div>

        <div id="option-content1" class="option-content">
            <table class="uk-table uk-table-small">
                <tbody>
                    <tr>
                        <th class="uk-table-expand">Dosing</th>
                        <td>
                            <strong class="highlight">Adults</strong> <br>
                            10 - 15 mg/kg <br><br>
                            <strong class="highlight">Children</strong> <br>
                            No established dose <br><br>
                            <strong class="highlight">Max dose</strong> <br> 450 mg
                        </td>
                    </tr>
                    <tr>
                        <th>Frequency</th>
                        <td>Daily</td>
                    </tr>
                    <tr>
                        <th class="uk-table-expand">Adverse Reactions</th>
                        <td>
                            GI upset, dizziness, hypersensitivity, Headaches, QT prolongation, tendon rupture (rare), arthralgia, increased risk for aortic dissection/rupture, hypo/hyperglycemia
                        </td>
                    </tr>
                </tbody>
            </table>
            
            <p>Additional Notes:</p>
            <p>Expert consultation is advised before use; agent is not approved for children less than 18 years of age.</p>
        </div>

        <div id="option-content2" class="option-content">
            <table class="uk-table uk-table-small">
                <tbody>
                    <tr>
                        <th>Dosing (A for adults, C for children)</th>

                        <td>
                            <strong class="highlight">Adults</strong> <br>
                            600 mg <br><br>

                            <strong class="highlight">Children < 12 years</strong>
                            <ul>
                                <li>5 – 10 kg: 15 mg/kg</li>
                                <li>10 – 23 kg: 12 mg/kg</li>
                                <li>>23 kg: 10 mg/kg</li>
                            </ul>

                            <strong class="highlight">Childrenl ≥ 12 years</strong> <br>
                             10 mg/kg <br><br>

                            <strong class="highlight">Max dose</strong> <br> 600 mg
                        </td>
                    </tr>
                    <tr>
                        <th>Frequency</th>
                        <td>Daily</td>
                    </tr>
                    <tr>
                        <th>Adverse Reactions</th>
                        <td>
                            Myelosuppression, GI upset, optic and peripheral neuropathy (may be irreversible)
                        </td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div id="option-content3" class="option-content">
            <table class="uk-table uk-table-small">
                <tbody>
                     <tr>
                        <th class="uk-table-expand">Dosing</th>
                        <td>
                            <strong class="highlight">Adults</strong> <br>
                            10 to 15 mg/kg/day  <br><br>
                            <strong class="highlight">Children</strong> <br>
                            15 to 30 mg/kg/day (max dose 1 gram)<br><br>
                        </td>
                    </tr>
                    <tr>
                        <th>Frequency</th>
                        <td>5-7 days per week or 3 times per week</td>
                    </tr>
                    <tr>
                        <th>Adverse Reactions</th>
                        <td>
                            Auditory, vestibular and renal toxicity
                        </td>
                    </tr>
                </tbody>
            </table>
            
            <p>Additional Notes:</p>
            <p>Dosing above for persons with CrCL > 50 mL/min. For persons with renal impairment, see Table 13.</p>
        </div>
    </div>
</div>
</body>
<script src="../assets/uikit.js" type="text/javascript"></script>
<script src="../assets/uikit-icons.js" type="text/javascript"></script>
<script src="main.js" type="text/javascript"></script>
</html>
